Patents Protecting Biologics or Small Molecule Drugs Are Litigated, Not Others Awarded to Drug Discovery Companies

SSRN Electronic Journal
doi 10.2139/ssrn.2807250
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Genomic Approaches to Small Molecule Discovery

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Advances in Small-Molecule Drug Discovery for Triple-Negative Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2015English

Structure-Based DNA-Targeting Strategies With Small Molecule Ligands for Drug Discovery

Medicinal Research Reviews
Drug DiscoveryMolecular MedicinePharmacology
2013English

Small Molecule PROTACs: An Emerging Technology for Targeted Therapy in Drug Discovery

RSC Advances
ChemistryChemical Engineering
2019English

Binding of Small Molecule Drugs to Porcine Vitreous Humor

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2018English

Discovery and Characterization of Small Molecule Rac1 Inhibitors

Oncotarget
Oncology
2017English

Do Small Companies Have Superior Financial Expertise or Are They Just Managing Earnings?

International Business & Economics Research Journal (IBER)
2012English

Discovery of a Small Molecule Insulin Receptor Activator

Recent Progress in Hormone Research
2001English

Patients Not Patents: Drug Research and Development as a Public Enterprise

European Journal of Clinical Investigation
MedicineBiochemistryClinical Biochemistry
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy